These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36949601)

  • 21. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems.
    Worel N; Greinix HT; Schneider B; Kurz M; Rabitsch W; Knöbl P; Reiter E; Derfler K; Fischer G; Hinterberger W; Höcker P; Kalhs P
    Transfusion; 2000 May; 40(5):543-50. PubMed ID: 10827256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
    Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant.
    Vivero A; Peedin AR; Gao Y; Karp JK
    J Clin Apher; 2023 Aug; 38(4):495-499. PubMed ID: 36703597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Ataca Atilla P; Akkus E; Atilla E; Gokmen N; Civriz Bozdag S; Kocak Toprak S; Kurt Yuksel M; Ozcan M; Demirer T; Ilhan O; Beksac M; Akan H; Arslan O; Topcuoglu P; Gurman G
    Transfus Clin Biol; 2020 Aug; 27(3):115-121. PubMed ID: 32659269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The devil is in the details: retention of recipient group A type 5 years after a successful allogeneic bone marrow transplant from a group O donor.
    Cooling LLW; Herrst M; Hugan SL
    Immunohematology; 2018 Jan; 33(1):19-22. PubMed ID: 29608324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pure red cell aplasia following ABO-incompatible allogeneic hematopoietic stem cell transplantation].
    Fan H; Jing Y; Li HH; Lu XC; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):364-7. PubMed ID: 18426666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.
    Wang Z; Sorror ML; Leisenring W; Schoch G; Maloney DG; Sandmaier BM; Storb R
    Br J Haematol; 2010 Apr; 149(1):101-10. PubMed ID: 20067562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation.
    Goldman J; Liesveld J; Nichols D; Heal J; Blumberg N
    Leuk Res; 2003 Jun; 27(6):489-91. PubMed ID: 12648507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.
    De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
    Labar B; Bogdanić V; Nemet D; Kovacević-Metelko J; Mrsić M; Pavletić Z; Zupancić-Salek S; Radman I; Aurer I
    Bone Marrow Transplant; 1992 Nov; 10(5):471-2. PubMed ID: 1464014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch.
    Warkentin PI; Hilden JM; Kersey JH; Ramsay NK; McCullough J
    Vox Sang; 1985; 48(2):89-104. PubMed ID: 2416122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of ABO-incompatibility on allogeneic hematopoietic stem cell transplantation].
    Bao L; Huang XJ; Liu KY; Xu LP; Chen H; Zhang YC; Chen YH; Han W; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):126-9. PubMed ID: 15841137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation.
    Bolan CD; Leitman SF; Griffith LM; Wesley RA; Procter JL; Stroncek DF; Barrett AJ; Childs RW
    Blood; 2001 Sep; 98(6):1687-94. PubMed ID: 11535498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
    Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
    Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Gao Y; Gao F; Shi J; Fu H; Huang H; Zhao Y
    J Zhejiang Univ Sci B; 2021 Aug; 22(8):695-700. PubMed ID: 34414703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
    Atay D; Erbey F; Akcay A; Ozturk G
    Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning.
    Marenchino D; Maddalena L; Balbo R; Avonto I; Menardi G; Prucca M; Perotti L; Mordini N; Peano G
    Blood Transfus; 2011 Jan; 9(1):79-85. PubMed ID: 21084015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.